Correlation between microRNA-320 and postoperative delirium in patients undergoing tibial fracture internal fixation

Bin Wang1, Zeng Yin2, Yanan Lin3

  • 1Department of Anesthesiology, Qingdao Municipal Hospital Affiliated to Qingdao University, NO. 5 Donghai Middle Road, Qingdao, 266071, Shandong, China.

BMC Anesthesiology
|March 23, 2022
PubMed
Abstract

Insights

MicroRNA-320 (miRNA-320) may contribute to postoperative delirium (POD) by increasing insulin-like growth factor-1 (IGF-1) and amyloid precursor protein (APP). Targeting miRNA-320 could offer a new therapeutic strategy for POD.

Area of Science:

  • Neuroscience
  • Biochemistry
  • Gerontology

Background:

  • Postoperative delirium (POD) incidence is rising in the elderly, yet its pathogenesis remains unclear.
  • MicroRNA-320 (miRNA-320) is a potential factor in POD, suggested by preliminary animal and human studies.

Purpose of the Study:

  • To investigate the role of miRNA-320 in the pathogenesis of POD.
  • To explore miRNA-320 as a potential therapeutic target for POD.

Main Methods:

  • An animal study using aged rats (control, anesthesia/surgery, saline, agomir-320, antagomir-320) assessed spatial learning and memory.
  • Plasma levels of insulin-like growth factor-1 (IGF-1), amyloid precursor protein (APP), miRNA-320, and IGF-1 mRNA were measured.
  • A human study (PNDABLE) included 240 elderly patients undergoing tibial fracture fixation, comparing POD cases with matched controls.

Main Results:

  • In rats, anesthesia/surgery upregulated miR-320 and APP while downregulating IGF-1 mRNA, impairing cognitive function.
  • Agomir-320 mimicked these effects, while antagomir-320 reversed them.
  • POD patients exhibited increased plasma miR-320 and APP, and decreased IGF-1 mRNA compared to controls.

Conclusions:

  • MiRNA-320 appears to play a role in POD pathogenesis by potentially upregulating IGF-1 mRNA and APP protein.
  • Targeting miRNA-320 presents a novel therapeutic avenue for managing POD.